Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1992;19:643-647

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pegoraro, A. A.
Right arrow Articles by Beierwaltes, W. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pegoraro, A. A.
Right arrow Articles by Beierwaltes, W. H.

Hypertension, Vol 19, 643-647, Copyright © 1992 by American Heart Association


ARTICLES

Sympathetic modulation of endothelium-derived relaxing factor

AA Pegoraro, OA Carretero, DH Sigmon and WH Beierwaltes
Department of Medicine, Henry Ford Hospital, Detroit, Mich 48202.

To determine whether the release of endothelium-derived relaxing factor (EDRF) is sympathetically mediated, we studied the effects of beta- blockade by propranolol, ganglionic blockade with hexamethonium, or mechanical pithing on the blood pressure response to EDRF inhibition in anesthetized rats. We inhibited EDRF with 10 mg/kg of either NG- monomethyl-L-arginine (L-NMMA) or N omega-nitro-L-arginine-methyl ester (L-NAME). In controls, L-NMMA and L-NAME increased blood pressure by 14 +/- 1 (p less than 0.01) and 22 +/- 2 mm Hg (p less than 0.01), respectively. Propranolol lowered blood pressure from 98 +/- 3 to 72 +/- 4 mm Hg without altering the response to L-NAME (delta 26 +/- 3). This response correlated with the resting blood pressure (r = 0.87; p less than 0.001). Hexamethonium (25 mg/kg) lowered blood pressure from 118 +/- 6 to 85 +/- 4 mm Hg but did not change the response to L-NMMA (delta 15 +/- 1). In pithed rats, blood pressure was lowered, but the pressor response to L-NAME was unchanged. When blood pressure was returned to normotensive levels by angiotensin II, norepinephrine, or phenylephrine, L-NAME increased blood pressure by 50 +/- 2, 68 +/- 8, and 109 +/- 7 mm Hg, respectively (p less than 0.001). We conclude that an intact autonomic nervous system is not needed for the pressor response to EDRF inhibition. The enhanced response in pithed rats treated with vasoconstrictors may be due to removal of the buffering effect of the baroreceptors and the absence of EDRF, which would oppose vasoconstriction.(ABSTRACT TRUNCATED AT 250 WORDS)


This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. L. Fellet, A. M. Balaszczuk, C. Arranz, J. J. Lopez-Costa, A. Boveris, and J. Bustamante
Autonomic regulation of pacemaker activity: role of heart nitric oxide synthases
Am J Physiol Heart Circ Physiol, September 1, 2006; 291(3): H1246 - H1254.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
K. Ayajiki, H. Fujioka, K. Shinozaki, and T. Okamura
Effects of capsaicin and nitric oxide synthase inhibitor on increase in cerebral blood flow induced by sensory and parasympathetic nerve stimulation in the rat
J Appl Physiol, May 1, 2005; 98(5): 1792 - 1798.
[Abstract] [Full Text] [PDF]


Home page
Exp PhysiolHome page
A. L. Fellet, P. Arza, N. Arreche, C. Arranz, and A. M. Balaszczuk
Nitric oxide and thyroid gland: modulation of cardiovascular function in autonomic-blocked anaesthetized rats
Exp Physiol, May 1, 2004; 89(3): 303 - 312.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
J. Zanzinger
Role of nitric oxide in the neural control of cardiovascular function
Cardiovasc Res, August 15, 1999; 43(3): 639 - 649.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Y. Fujisawa, N. Mori, K. Yube, H. Miyanaka, A. Miyatake, and Y. Abe
Role of nitric oxide in regulation of renal sympathetic nerve activity during hemorrhage in conscious rats
Am J Physiol Heart Circ Physiol, July 1, 1999; 277(1): H8 - H14.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
N. Iida
Nitric oxide mediates sympathetic vasoconstriction at supraspinal, spinal, and synaptic levels
Am J Physiol Heart Circ Physiol, March 1, 1999; 276(3): H918 - H925.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
C. Baylis, J. Harvey, B. R. Santmyire, and K. Engels
Pressor and Renal Vasoconstrictor Responses to Acute Systemic Nitric Oxide Synthesis Inhibition Are Independent of the Sympathetic Nervous System and Angiotensin II
J. Pharmacol. Exp. Ther., February 1, 1999; 288(2): 693 - 698.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
C. S. Wilcox, X. Deng, and W. J. Welch
NO generation and action during changes in salt intake: roles of nNOS and macula densa
Am J Physiol Regulatory Integrative Comp Physiol, June 1, 1998; 274(6): R1588 - R1593.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
Y. Zagvazdin, A. Reiner, I. F. Benter, M. Sander, J. Hansen, and R. G. Victor
Central Nervous System Is Not Involved in Initiation of the Pressor Effect of 7-Nitroindazole in Urethane-Anesthetized Rats • Response
Hypertension, February 1, 1998; 31 (2): 719 - 720.
[Full Text]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
H. I. Chen and C. T. Hu
Endogenous nitric oxide on arterial hemodynamics: a comparison between normotensive and hypertensive rats
Am J Physiol Heart Circ Physiol, October 1, 1997; 273(4): H1816 - H1823.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
H.-J. Habler, G. Wasner, and W. Janig
Attenuation of Neurogenic Vasoconstriction by Nitric Oxide in Hindlimb Microvascular Beds of the Rat In Vivo
Hypertension, October 1, 1997; 30(4): 957 - 961.
[Abstract] [Full Text]


Home page
HypertensionHome page
T. Okamura, K. Ayajiki, and N. Toda
Neural Mechanism of Pressor Action of Nitric Oxide Synthase Inhibitor in Anesthetized Monkeys
Hypertension, September 1, 1996; 28(3): 341 - 346.
[Abstract] [Full Text]


Home page
HypertensionHome page
R. L. Davisson, J. N. Bates, A. K. Johnson, and S. J. Lewis
Use-Dependent Loss of Acetylcholine- and Bradykinin-Mediated Vasodilation After Nitric Oxide Synthase Inhibition: Evidence for Preformed Stores of Nitric Oxide–Containing Factors in Vascular Endothelial Cells
Hypertension, September 1, 1996; 28(3): 354 - 360.
[Abstract] [Full Text]


Home page
CirculationHome page
V. Richard, M. Hogie, M. Clozel, B.-M. Loffler, and C. Thuillez
In Vivo Evidence of an Endothelin-Induced Vasopressor Tone After Inhibition of Nitric Oxide Synthesis in Rats
Circulation, February 1, 1995; 91(3): 771 - 775.
[Abstract] [Full Text]